Purdue To Settle OxyContin Antitrust MDL: Atty

By Erin Fuchs

Law360, New York (March 17, 2010, 5:42 PM ET) -- Purdue Pharma LP has settled a slew of suits brought by indirect buyers of OxyContin accusing it of stifling generic competition by filing bogus patent litigation, just days after its lawyer told a judge that the drugmaker anticipates settling all of the pending cases in the multidistrict litigation.

Judge Sidney H. Stein of the U.S. District Court for the Southern District of New York signed off Wednesday on settlement agreements ending two individual plaintiffs' indirect purchaser antitrust suits against Purdue.

The development comes on the heels...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles